Porcine circoviruses, vaccines and diagnostic reagents
US7122192B2 · kind B2 · utility
58Cited by
2References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2003 |
| Grant date | Oct 17, 2006 |
| Priority date | — |
| Expiry date | Oct 24, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/10064
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new porcine circovirus strains isolated from pulmonary or ganglionic samples obtained from farms affected by the post-weaning multisystemic wasting syndrome (PMWS). It relates to purified preparations of these strains, conventional attenuated or inactivated vaccines, recombinant live vaccines, plasmid vaccines and subunit vaccines, as well as reagents and diagnostic methods. It also relates to the DNA fragments which can be used for the production of subunits in an in vitro expression vector or as sequences to be integrated into a virus or plasmid type in vivo expression vector.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.